1qnh

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /><applet load="1qnh" size="450" color="white" frame="true" align="right" spinBox="true" caption="1qnh, resolution 2.1&Aring;" /> '''PLASMODIUM FALCIPARUM...)
Line 1: Line 1:
-
[[Image:1qnh.jpg|left|200px]]<br /><applet load="1qnh" size="450" color="white" frame="true" align="right" spinBox="true"
+
[[Image:1qnh.jpg|left|200px]]<br /><applet load="1qnh" size="350" color="white" frame="true" align="right" spinBox="true"
caption="1qnh, resolution 2.1&Aring;" />
caption="1qnh, resolution 2.1&Aring;" />
'''PLASMODIUM FALCIPARUM CYCLOPHILIN (DOUBLE MUTANT) COMPLEXED WITH CYCLOSPORIN A'''<br />
'''PLASMODIUM FALCIPARUM CYCLOPHILIN (DOUBLE MUTANT) COMPLEXED WITH CYCLOSPORIN A'''<br />
==Overview==
==Overview==
-
Cyclosporin A (CsA) is a potent anti-malarial compound in vitro and in, vivo in mice though better known for its immunosuppressive properties in, humans. Crystal structures of wild-type and a double mutant Plasmodium, falciparum cyclophilin (PfCyP19 and mPfCyP19) complexed with CsA have been, determined using diffraction terms to a resolution of 2.1 A (1 A=0.1 nm)., The wild-type has a single PfCyP19/CsA complex per asymmetric unit in, space group P1 and refined to an R-work of 0.15 and R-free of 0.19. An, altered cyclophilin, with two accidental mutations, Phe120 to Leu in the, CsA binding pocket and Leu171 to Trp at the C terminus, presents two, complexes per asymmetric unit in the orthorhombic space group P2(1)2(1)2., This refined to an R-work of 0.18 and R-free 0.21. The mutations were, identified from the crystallographic analysis and the C-terminal, alteration helps to explain the different crystal forms obtained. PfCyP19, shares approximately 61 % sequence identity with human cyclophilin A, (hCyPA) and the structures are similar, consisting of an eight-stranded, antiparallel beta-barrel core capped by two alpha-helices. The fold, creates a hydrophobic active-site, the floor of which is formed by, side-chains of residues from four antiparallel beta-strands and the walls, from loops and turns. We identified C-H.O hydrogen bonds between the drug, and protein that may be an important feature of cyclophilins and suggest a, general mode of interaction between hydrophobic molecules. Comparisons, with cyclophilin-dipeptide complexes suggests that a specific C-H.O, hydrogen bonding interaction may contribute to ligand binding. Residues, Ser106, His99 and Asp130, located close to the active site and conserved, in most cyclophilins, are arranged in a manner reminiscent of a serine, protease catalytic triad. A Ser106Ala mutant was engineered to test the, hypothesis that this triad contributes to CyP function. Mutant and, wild-type enzymes were found to have similar catalytic properties.
+
Cyclosporin A (CsA) is a potent anti-malarial compound in vitro and in vivo in mice though better known for its immunosuppressive properties in humans. Crystal structures of wild-type and a double mutant Plasmodium falciparum cyclophilin (PfCyP19 and mPfCyP19) complexed with CsA have been determined using diffraction terms to a resolution of 2.1 A (1 A=0.1 nm). The wild-type has a single PfCyP19/CsA complex per asymmetric unit in space group P1 and refined to an R-work of 0.15 and R-free of 0.19. An altered cyclophilin, with two accidental mutations, Phe120 to Leu in the CsA binding pocket and Leu171 to Trp at the C terminus, presents two complexes per asymmetric unit in the orthorhombic space group P2(1)2(1)2. This refined to an R-work of 0.18 and R-free 0.21. The mutations were identified from the crystallographic analysis and the C-terminal alteration helps to explain the different crystal forms obtained. PfCyP19 shares approximately 61 % sequence identity with human cyclophilin A (hCyPA) and the structures are similar, consisting of an eight-stranded antiparallel beta-barrel core capped by two alpha-helices. The fold creates a hydrophobic active-site, the floor of which is formed by side-chains of residues from four antiparallel beta-strands and the walls from loops and turns. We identified C-H.O hydrogen bonds between the drug and protein that may be an important feature of cyclophilins and suggest a general mode of interaction between hydrophobic molecules. Comparisons with cyclophilin-dipeptide complexes suggests that a specific C-H.O hydrogen bonding interaction may contribute to ligand binding. Residues Ser106, His99 and Asp130, located close to the active site and conserved in most cyclophilins, are arranged in a manner reminiscent of a serine protease catalytic triad. A Ser106Ala mutant was engineered to test the hypothesis that this triad contributes to CyP function. Mutant and wild-type enzymes were found to have similar catalytic properties.
==About this Structure==
==About this Structure==
-
1QNH is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Plasmodium_falciparum Plasmodium falciparum] and [http://en.wikipedia.org/wiki/Tolypocladium_inflatum Tolypocladium inflatum]. Active as [http://en.wikipedia.org/wiki/Peptidylprolyl_isomerase Peptidylprolyl isomerase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=5.2.1.8 5.2.1.8] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1QNH OCA].
+
1QNH is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Plasmodium_falciparum Plasmodium falciparum] and [http://en.wikipedia.org/wiki/Tolypocladium_inflatum Tolypocladium inflatum]. Active as [http://en.wikipedia.org/wiki/Peptidylprolyl_isomerase Peptidylprolyl isomerase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=5.2.1.8 5.2.1.8] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1QNH OCA].
==Reference==
==Reference==
Line 15: Line 15:
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Tolypocladium inflatum]]
[[Category: Tolypocladium inflatum]]
-
[[Category: Hall, D.R.]]
+
[[Category: Hall, D R.]]
-
[[Category: Hunter, W.N.]]
+
[[Category: Hunter, W N.]]
-
[[Category: Peterson, M.R.]]
+
[[Category: Peterson, M R.]]
[[Category: cyclophilin a]]
[[Category: cyclophilin a]]
[[Category: cyclosporin a]]
[[Category: cyclosporin a]]
[[Category: peptidyl cis-trans isomerase]]
[[Category: peptidyl cis-trans isomerase]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Sun Nov 25 04:15:18 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 14:41:44 2008''

Revision as of 12:41, 21 February 2008


1qnh, resolution 2.1Å

Drag the structure with the mouse to rotate

PLASMODIUM FALCIPARUM CYCLOPHILIN (DOUBLE MUTANT) COMPLEXED WITH CYCLOSPORIN A

Overview

Cyclosporin A (CsA) is a potent anti-malarial compound in vitro and in vivo in mice though better known for its immunosuppressive properties in humans. Crystal structures of wild-type and a double mutant Plasmodium falciparum cyclophilin (PfCyP19 and mPfCyP19) complexed with CsA have been determined using diffraction terms to a resolution of 2.1 A (1 A=0.1 nm). The wild-type has a single PfCyP19/CsA complex per asymmetric unit in space group P1 and refined to an R-work of 0.15 and R-free of 0.19. An altered cyclophilin, with two accidental mutations, Phe120 to Leu in the CsA binding pocket and Leu171 to Trp at the C terminus, presents two complexes per asymmetric unit in the orthorhombic space group P2(1)2(1)2. This refined to an R-work of 0.18 and R-free 0.21. The mutations were identified from the crystallographic analysis and the C-terminal alteration helps to explain the different crystal forms obtained. PfCyP19 shares approximately 61 % sequence identity with human cyclophilin A (hCyPA) and the structures are similar, consisting of an eight-stranded antiparallel beta-barrel core capped by two alpha-helices. The fold creates a hydrophobic active-site, the floor of which is formed by side-chains of residues from four antiparallel beta-strands and the walls from loops and turns. We identified C-H.O hydrogen bonds between the drug and protein that may be an important feature of cyclophilins and suggest a general mode of interaction between hydrophobic molecules. Comparisons with cyclophilin-dipeptide complexes suggests that a specific C-H.O hydrogen bonding interaction may contribute to ligand binding. Residues Ser106, His99 and Asp130, located close to the active site and conserved in most cyclophilins, are arranged in a manner reminiscent of a serine protease catalytic triad. A Ser106Ala mutant was engineered to test the hypothesis that this triad contributes to CyP function. Mutant and wild-type enzymes were found to have similar catalytic properties.

About this Structure

1QNH is a Single protein structure of sequence from Plasmodium falciparum and Tolypocladium inflatum. Active as Peptidylprolyl isomerase, with EC number 5.2.1.8 Full crystallographic information is available from OCA.

Reference

The three-dimensional structure of a Plasmodium falciparum cyclophilin in complex with the potent anti-malarial cyclosporin A., Peterson MR, Hall DR, Berriman M, Nunes JA, Leonard GA, Fairlamb AH, Hunter WN, J Mol Biol. 2000 Apr 21;298(1):123-33. PMID:10756109

Page seeded by OCA on Thu Feb 21 14:41:44 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools